Mick Foy | Group Manager of Vigilance Intelligence and Research Group
M.H.R.A.

Mick Foy, Group Manager of Vigilance Intelligence and Research Group, M.H.R.A.

Appearances:



World Drug Safety Europe Day Two (Wednesday 13 September ) @ 09:45

Keynote Panel discussion: Updates on European pharmacovigilance regulation and their implications for the industry

Master Drug Safety EU
  • Achieving greater collaboration with medicines regulators across Europe and ensuring a smoother launch of new products
  • Examining developments in GVP measures and status of the new Module VI
  • Managing and reporting of adverse reactions to medicinal products
Liana Gross Martirosyan, Pharmacovigilance Assessor, Dutch Medicines Evaluation Board
Shelly Goodman, Head of Global Pharmacovigilance and Drug Safety, Portola Pharmaceuticals , Inc.
Mick Foy, Group Manager of Vigilance Intelligence and Research Group, M.H.R.A.
Doris Stenver, Chief Medical Officer, member of PRAC at EMA, Danish Medicines Agency

back to speakers